For example, GLP-1 RA administration downregulates the conversion of astrocytes, inhibits neurodegeneration, and prevents cognitive impairments in animal models of Alzheimer’s disease [44]. The gene discussed is GLP1R; the disease is early-onset autosomal dominant Alzheimer disease.